688192.SS
688192.SS
CNE1000055W8
DIZAL PHARMACEUTICAL CO LTD
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
27.89B EUR
18.57B EUR
25.21B EUR
Enterprise Value
27.5B EUR
19.75B EUR
26.43B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
90.83x
--
--
Price to Sales
28.78x
19.91x
30.65x
Price to Book
24.68x
16.44x
20.42x
EV/Revenue
28.39x
21.17x
32.14x
EV/EBITDA
-45.12x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-2.22%
-3.64%
-3.16%
ende